Marc Tessier-Lavigne - Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
DNLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Marc Tessier-Lavigne since 7/7/2023

Holdings reported by Marc Tessier-Lavigne for Denali Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 1,880,539 $38.3 M $20.39 May 31, 2024 Direct
Common Stock 79,173 $1.61 M $20.39 May 31, 2024 The Tessier-Lavigne/Hynes Irrevocable Trust 2
Common Stock 78,848 $1.61 M $20.39 May 31, 2024 The Tessier-Lavigne/Hynes Irrevocable Trust 1
Common Stock 78,848 $1.61 M $20.39 May 31, 2024 The Tessier-Lavigne/Hynes Irrevocable Trust 3
Stock Option (right to buy) 17,901 May 31, 2024 Direct Common Stock

Transactions reported by Marc Tessier-Lavigne for Denali Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership